Tenboron Overview

  • Founded
  • 2010
Founded
  • Status
  • Private
  • Employees
  • 2
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $1.66M
Latest Deal Amount
  • Investors
  • 3

Tenboron General Information

Description

Developer of a boron neutron capture therapy intended to treat locally invasive malignant tumors. The company's therapy solutions focus on the development and commercialization of targeted carrier compounds to reduce the bulge of tumors, enabling patients to get treatment of invasive malignant tumors.

Contact Information

Website
www.tenboron.fi
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Primary Office
  • Viikinkaari 6
  • 00790 Helsinki
  • Finland
+358 050 0000000

Tenboron Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Tenboron Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 23-Sep-2020 $1.66M 00.000 000.00 Completed Generating Revenue
4. Later Stage VC 23-Apr-2019 00.000 00.000 000.00 Completed Pre-Clinical Trials
3. Seed Round 24-Feb-2016 00.000 00.000 00.000 Completed Generating Revenue
2. Seed Round 19-Nov-2013 $1.7M $3.38M 00.000 Completed Product In Beta Test
1. Seed Round 03-Nov-2011 $1.68M $1.68M 00.000 Completed Product In Beta Test
To view Tenboron’s complete valuation and funding history, request access »

Tenboron Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 0,000 0000.00 0000.00 00 0000.00 0.000
Ordinary 0,000 0000.00 0000.00 00 0000.00 00.000
Ordinary 00,000 000.00 000.00 00 000.00 00.000
Ordinary 7,950 $186.12 $186.12 1x $186.12 15.26%
Ordinary 6,350 $227.61 $227.61 1x $227.61 12.19%
To view Tenboron’s complete cap table history, request access »

Tenboron Executive Team (4)

Name Title Board Seat Contact Info
Juha Jouhki Chief Executive Officer
Seppo Pakkala Ph.D Co-Founder, Chief Medical Officer & Chairman
Jari Helin Chief Development Officer
You’re viewing 3 of 4 executive team members. Get the full list »

Tenboron Board Members (3)

Name Representing Role Since
Juhani Saarinen Tenboron Board Member 000 0000
Seppo Pakkala Ph.D Tenboron Co-Founder, Chief Medical Officer & Chairman 000 0000
You’re viewing 2 of 3 board members. Get the full list »

Tenboron Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tenboron Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Innovestor Venture Capital Minority 000 0000 000000 0
Finnvera Venture Capital Minority 000 0000 000000 0
Tekes Not-For-Profit Venture Capital Minority 000 0000 000000 0
To view Tenboron’s complete investors history, request access »